The Centers for Disease Control and Prevention on Wednesday recommended Novavax’s Covid boosters for adults in the U.S., including for people who received Pfizer, Moderna or Johnson & Johnson’s shots as their primary series.
The Food and Drug Administration, in a factsheet for healthcare providers, said adults ages 18 and older can receive Novavax as their third dose six months after completion of the primary series of a U.S. authorized Covid vaccine.
The CDC gave the final go ahead for pharmacies to start administering the Novavax boosters just hours after the FDA had authorized the shots. Dr. Evelyn Twentyman, a CDC official, announced the Novavax recommendation during a meeting of the agency’s independent vaccine experts Wednesday afternoon.